Givaudan SA

GIVN: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|DsLOCK|kC#LOCK|^s#xv>>

Givaudan Earnings: Sales Growth Normalizes While Long-Term Targets Remain Intact; Shares Undervalued

Givaudan reported like-for-like sales growth of 5.1% for full-year 2025, with growth slowing sequentially in the fourth quarter. Weaker sales led to a 30-basis-point reduction in the full-year comparable EBITDA margin. Shares declined 6% at the opening of the market on Jan. 29.

Sponsor Center